The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-(3,5-dimethoxyphenylamino)-4-(2-methoxy-4-methylphenoxy)pyrimidin-5-yl)-3-(4-methoxyphenyl)urea ID: ALA4171175
PubChem CID: 142749658
Max Phase: Preclinical
Molecular Formula: C28H29N5O6
Molecular Weight: 531.57
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(NC(=O)Nc2cnc(Nc3cc(OC)cc(OC)c3)nc2Oc2ccc(C)cc2OC)cc1
Standard InChI: InChI=1S/C28H29N5O6/c1-17-6-11-24(25(12-17)38-5)39-26-23(32-28(34)31-18-7-9-20(35-2)10-8-18)16-29-27(33-26)30-19-13-21(36-3)15-22(14-19)37-4/h6-16H,1-5H3,(H,29,30,33)(H2,31,32,34)
Standard InChI Key: UJPUZWUQPJPBIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
20.2014 -21.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2002 -21.8560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9083 -22.2649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6179 -21.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6151 -21.0328 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9065 -20.6276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9040 -19.8104 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6105 -19.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3173 -19.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0233 -19.3985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0213 -18.5805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3074 -18.1742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6044 -18.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3263 -22.2630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0333 -21.8533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7384 -22.2612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4449 -21.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4441 -21.0341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7308 -20.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0271 -21.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8937 -18.1830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8878 -17.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7273 -18.1688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7266 -19.8096 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4322 -19.3974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1531 -22.2600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8604 -21.8506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4936 -20.6280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7859 -21.0368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0781 -20.6284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7861 -21.8540 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3705 -21.0371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6632 -20.6269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9561 -21.0350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9559 -21.8531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6687 -22.2614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3729 -21.8509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2488 -22.2628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5405 -21.8553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
4 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
13 21 1 0
21 22 1 0
11 23 1 0
19 24 1 0
24 25 1 0
17 26 1 0
26 27 1 0
1 28 1 0
28 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
35 38 1 0
38 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 531.57Molecular Weight (Monoisotopic): 531.2118AlogP: 6.00#Rotatable Bonds: 10Polar Surface Area: 125.09Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3CX Acidic pKa: 10.43CX Basic pKa: 2.24CX LogP: 5.29CX LogD: 5.29Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.23Np Likeness Score: -1.11
References 1. Farag AK, Elkamhawy A, Londhe AM, Lee KT, Pae AN, Roh EJ.. (2017) Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders., 141 [PMID:29107425 ] [10.1016/j.ejmech.2017.10.003 ]